Adam (HTT) is a UK-based startup founded in 2011, operating in the health care industry. The company's flagship product, Human Touch Technology ™, aims to revolutionize the commissioning process in the public sector, ensuring a focus on quality and outcomes while effectively managing spending. The exclusive technology used by Adam (HTT) enables Public Sector commissioners to prioritize the individual, emphasizing outcomes and human-centric evaluation.
The recent £5.00M debt financing investment, received on 21 June 2021 from BOOST&Co, underscores the investor confidence in Adam (HTT)'s unique approach to public sector commissioning. This funding is a testament to the company's potential and signifies a step forward in advancing their pioneering category development system.
Adam (HTT) offers a comprehensive, end-to-end solution, leveraging their technology to streamline the commissioning process, making it more efficient and quality-driven. By freeing up time and resources for the category teams, the innovative technology ultimately empowers them to focus on service delivery, marking a significant shift towards a more people-centric approach in the public sector. The company's commitment to putting the public sector back in control positions Adam (HTT) at the forefront of shaping the future of commissioning for complex services.